SCHEMBL14423916

SCHEMBL14423916

CCNC(=O)Nc1ccc(Oc2ccnc3cc(OC4CCCN(C)C4)c(C#N)cc23)cc1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 9/20 0.44
PDGFRA P16234 6/20 0.44
MET P08581 6/20 0.40
AXL P30530 3/20 0.40
RET P07949 4/20 0.39
FGFR2 P21802 3/20 0.39
FGFR4 P22455 3/20 0.39
FGFR1 P11362 2/20 0.39
FGFR3 P22607 2/20 0.39
LCK P06239 2/20 0.38
KIT P10721 4/20 0.38
PDGFRB P09619 2/20 0.38
FLT4 P35916 2/20 0.38
RIPK2 O43353 1/20 0.38
ERN1 O75460 1/20 0.38
STK10 O94804 1/20 0.38
MAP3K6 O95382 1/20 0.38
ABL1 P00519 1/20 0.38
ESR1 P03372 1/20 0.38
ADORA3 P0DMS8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1889797 0.89 KDR (0.47) KDRPDGFRAMETAXLRET
SCHEMBL14423914 0.87 KDR (0.44) KDRPDGFRAMETAXLRET
SCHEMBL12673496 0.82 FGFR4 (0.49) KDRPDGFRAMETAXLRET
SCHEMBL1895288 0.82 KDR (0.46) KDRPDGFRAMETAXLRET
SCHEMBL12501394 0.81 PDGFRA (0.47) KDRPDGFRAMETAXLRET
SCHEMBL1894825 0.80 KDR (0.51) KDRPDGFRAMETAXLRET
SCHEMBL1895585 0.80 FGFR4 (0.49) KDRPDGFRARETFGFR2FGFR4
SCHEMBL12503756 0.80 KDR (0.48) KDRPDGFRAMETAXLRET
SCHEMBL1889799 0.79 KDR (0.45) KDRPDGFRAMETAXLRET
SCHEMBL1894701 0.79 KDR (0.49) KDRPDGFRAMETAXLRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed
US-7253286-B2 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective EISAI CO., LTD (JP) 2007-08-07 US disclosed